David Steffin, MD

Dr. David Steffin has a clinical expertise in hematopoietic stem cell transplant with a special emphasis in cellular therapies for relapsed/refractory solid tumors. He is also a member of the Center for Cell and Gene Therapy (CAGT) and the Dan L. Duncan Cancer Center at Baylor College of Medicine.

His research focuses on developing novel treatments for children with solid tumors by redirecting the immune system to attack and kill cancer cells using genetically-engineered T cells. Dr. Steffin is a principal investigator and co-investigator on a number of phase 1 clinical trials using CAR T cells to target solid tumors in children. He is also involved in several clinical projects within the bone marrow transplant unit to improve quality of care and patient safety.

Dr. Steffin is a graduate of the Technion-Israel Institute of Technology in Haifa, Israel. He completed his residency in pediatrics at Maimonides Medical Center in Brooklyn, NY. This was followed by his fellowship training in pediatric hematology/oncology and an additional year of subspecialty training in hematopoietic stem cell transplantation and immunotherapy at Texas Children’s Hospital/Baylor College of Medicine.